VeriMomginsenoside re est-il sûr pendant la grossesse ?
Limited reproductive/embryotoxicity evidence exists in non‑clinical studies (in vitro whole‑embryo culture and other lab studies reporting embryotoxic/teratogenic effects of isolated ginsenosides), but no harmonised CLP classification or convincing in‑vivo developmental toxicity data were found; CIR materials list ginsenosides as components of Panax extracts but do not give a harmonised reproductive hazard. Sources: PubMed embryotoxicity studies and reviews, CIR panel materials, LactMed review.
Alternatives sûres à ginsenoside re pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- ginsenoside re est-il sûr pendant la grossesse ?
- Limited reproductive/embryotoxicity evidence exists in non‑clinical studies (in vitro whole‑embryo culture and other lab studies reporting embryotoxic/teratogenic effects of isolated ginsenosides), but no harmonised CLP classification or convincing in‑vivo developmental toxicity data were found; CIR materials list ginsenosides as components of Panax extracts but do not give a harmonised reproductive hazard. Sources: PubMed embryotoxicity studies and reviews, CIR panel materials, LactMed review.
- ginsenoside re est-il sûr pendant l'allaitement ?
- Human data are lacking; reviews and LactMed note possible estrogenic activity of ginsenosides and advise caution in lactation, but no direct clinical breast‑milk transfer or adverse‑infant reports from topical cosmetic use were found. No harmonised classification or SCCS/CIR adverse conclusion specific to topical use was located.
- ginsenoside re est-il sûr pour la peau de bébé ?
- Hazard and mechanism scores kept the same as adult (no infant‑specific evidence to increase hazard/mechanism). Dermal absorption from cosmetics is expected to be low for a high‑MW saponin like ginsenoside Re (large glycoside), but infant skin permeability is higher so exposure score is increased by +1 for 0–3‑year‑old skin; no direct percutaneous absorption studies for ginsenoside Re in humans/infants were found.
- Comment VeriMom évalue-t-il ginsenoside re ?
- VeriMom évalue ginsenoside re à 67/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à ginsenoside re pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à ginsenoside re basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.